30 Day Trial

NuVasive Reports 4Q18 Revenue of $288.3MM, +6.3% vs. 4Q17

Share:

NuVasive posts 4Q18 revenue of USD $288.3MM, +6.3%vs. 4Q17, with 2018 full-year revenue of $1,101.7MM, +7.3% vs. 2017.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.